Suppr超能文献

前进之路:关于促进与孕妇相关研究的因素的见解。

The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women.

机构信息

Professor at the School of Law at the University of Washington and an associate director at the Institute for Public Health Genetics at the University of Washington.

Director of policy and government relations at BluePath Health.

出版信息

Ethics Hum Res. 2020 Jul;42(4):2-16. doi: 10.1002/eahr.500058.

Abstract

The near-routine exclusion of pregnant women from clinical research has resulted in evidence gaps that endanger the health of pregnant women and their future offspring. Although existing literature documents numerous obstacles along the clinical trial pathway that can stymie research involving pregnant women, there is little guidance on how to facilitate such research. This qualitative study aims to fill that void by examining the experiences of individuals involved in conducting, approving, or overseeing research involving pregnant women at one academic institution. The study identifies factors throughout the clinical pathway-from protocol development, to IRB review, and ultimately trial execution-that likely contribute to the successful conduct of research with pregnant women. Attention to those factors, coupled with agreement among stakeholders that research with pregnant women should and can be done ethically and legally, is critical to shifting the narrative from "why we cannot" do such research to "how we can."

摘要

将孕妇排除在临床研究之外已成为常态,这导致了危及孕妇及其后代健康的证据空白。尽管现有文献记录了临床研究路径中许多可能阻碍涉及孕妇的研究的障碍,但关于如何促进此类研究的指导却很少。这项定性研究旨在通过研究一家学术机构中参与进行、批准或监督涉及孕妇的研究的个人的经验来填补这一空白。该研究确定了临床途径中从方案制定到 IRB 审查,最终到试验执行的各个因素,这些因素可能会对成功进行涉及孕妇的研究产生影响。关注这些因素,以及利益相关者之间的共识,即研究涉及孕妇应该而且可以在伦理和法律上进行,对于从“为什么我们不能”进行此类研究转变为“我们如何能够”进行此类研究至关重要。

相似文献

1
The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women.
Ethics Hum Res. 2020 Jul;42(4):2-16. doi: 10.1002/eahr.500058.
3
American Society of Clinical Oncology policy statement: oversight of clinical research.
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
4
Enrolling pregnant women: issues in clinical research.
Womens Health Issues. 2013 Jan;23(1):e39-45. doi: 10.1016/j.whi.2012.10.003.
5
A qualitative study on acceptable levels of risk for pregnant women in clinical research.
BMC Med Ethics. 2017 May 15;18(1):35. doi: 10.1186/s12910-017-0194-9.
6
Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.
Clin Trials. 2015 Oct;12(5):485-93. doi: 10.1177/1740774515597687. Epub 2015 Sep 15.
7
IRB Decision-Making about Minimal Risk Research with Pregnant Participants.
Ethics Hum Res. 2021 Sep;43(5):2-17. doi: 10.1002/eahr.500100.
9
Accelerating the paradigm shift toward inclusion of pregnant women in drug research: Ethical and regulatory considerations.
Semin Perinatol. 2015 Nov;39(7):537-40. doi: 10.1053/j.semperi.2015.08.008. Epub 2015 Sep 16.
10
Institutional Review Boards: What Clinician Researchers Need to Know.
Mayo Clin Proc. 2019 Mar;94(3):515-525. doi: 10.1016/j.mayocp.2019.01.020.

引用本文的文献

1
Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review.
PLoS Med. 2024 May 30;21(5):e1004405. doi: 10.1371/journal.pmed.1004405. eCollection 2024 May.
2
IRB Decision-Making about Minimal Risk Research with Pregnant Participants.
Ethics Hum Res. 2021 Sep;43(5):2-17. doi: 10.1002/eahr.500100.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验